Outcome indicators differ between patients with CRVO versus BRVO
- Posted on: Feb 24 2020
- Leave a response
This study presents outcomes of patients treated with ranibizumab for branch and central retinal vein occlusion (BRVO and CRVO).
Source: AAO
Posted in: Uncategorized
